Signal Desk · Markets

MOFSL says Alkem faces consolidation phase into FY27

2026-11-13 · 1 source · Business Standard Markets

In short

MOFSL said Alkem will likely spend FY27 in a consolidation phase. The brokerage said the new business is still in a gestation period, with costs coming early and revenue not yet rising.

That means the company may need more time before the new business starts contributing meaningfully.

What the reporting says

MOFSL said FY27 will be a year of consolidation for Alkem as its new business goes through a gestation period before scaling up. The brokerage said operational costs are front-loaded while revenue has yet to pick up. The note explains why MOFSL kept a cautious stance on the company.

Why it matters

MOFSL said FY27 is a consolidation year for Alkem because the company’s new business is still in a gestation period. The brokerage noted that operational costs are front-loaded while revenue has yet to pick up. The comments reflect a cautious view on Alkem’s near-term earnings profile and growth from newer lines of business.

Touches: Alkem, Companies, Markets, Healthcare

Sources